Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA544518
Max Phase: Preclinical
Molecular Formula: C26H41ClN2
Molecular Weight: 380.62
Molecule Type: Small molecule
Associated Items:
ID: ALA544518
Max Phase: Preclinical
Molecular Formula: C26H41ClN2
Molecular Weight: 380.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCN=c1ccn(Cc2ccccc2)cc1.Cl
Standard InChI: InChI=1S/C26H40N2.ClH/c1-2-3-4-5-6-7-8-9-10-11-12-16-21-27-26-19-22-28(23-20-26)24-25-17-14-13-15-18-25;/h13-15,17-20,22-23H,2-12,16,21,24H2,1H3;1H
Standard InChI Key: YFXQOSMRTBHJCX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 380.62 | Molecular Weight (Monoisotopic): 380.3191 | AlogP: 7.14 | #Rotatable Bonds: 15 |
Polar Surface Area: 17.29 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.40 | CX LogP: 8.39 | CX LogD: 5.53 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.29 | Np Likeness Score: -0.34 |
1. Wentland MP, Bailey DM, Powles RG, Slee AM, Sedlock DM.. (1988) The in vitro dental plaque inhibitory properties of a series of N-[1-alkyl-4(1H)-pyridinylidene]alkylamines., 31 (10): [PMID:3172139] [10.1021/jm00118a030] |
Source(1):